P

Pontifax portfolio

Pontifax has 3 portfolio companies on record at Recent Funding. Its most recent investment on record is Agomab Therapeutics's $95.45M Series B+ round in October 2023, alongside Walleye Capital, Redmile Group, Pfizer and 6 others. By category, its portfolio leans toward Health and bio (3) and Legal and compliance (1). It has co-invested with Cormorant Asset Management, Redmile Group and OMNES Capital, most often Cormorant Asset Management (2 rounds).

What Pontifax invests in

• Health and bio · 3 · 100%
• Legal and compliance · 1 · 33%

Pontifax recent investments

Company	Round	Date	Alongside
AAgomab Therapeutics	Series B+ · $95.45M	Oct 11, 2023	Walleye Capital, Redmile Group, Pfizer +6
AAnaveon	Series B+ · $120M	Dec 16, 2021	Syncona Partners LLP, Pfizer Venture Investments, Novartis Venture Fund +2
AAgomab Therapeutics	Series B+ · $74M	Mar 10, 2021	V-Bio Ventures, Redmile Group (lead), OMNES Capital +4
AAgomab Therapeutics	Series A · $24M	Apr 1, 2019	V-Bio Ventures (lead), OMNES Capital, Boehringer Ingelheim Venture Fund +1

How Pontifax invests

Share is of the 4 rounds on Recent Funding that name Pontifax. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Pontifax portfolio companies

• AAgomab Therapeutics$95.45MSeries B+ · Oct 2023
• AAnaveon$120MSeries B+ · Dec 2021
• AAdcytherixbacker

Company	Round with Pontifax	Total raised	Latest raise
AAgomab Therapeutics Health and bio	Oct 11, 2023 Series B+ · $95.45M	$193.45M	Oct 11, 2023 Series B+
AAnaveon Legal and compliance	Dec 16, 2021 Series B+ · $120M	$155M	Dec 16, 2021 Series B+
AAdcytherix Health and bio	backer	undisclosed	Oct 16, 2025 Series A

Most frequent co-investors

• CCormorant Asset Management2 shared rounds · last Oct 11, 2023
• RRedmile Group2 shared rounds · last Oct 11, 2023
• OOMNES Capital2 shared rounds · last Mar 10, 2021
• BBoehringer Ingelheim Venture Fund2 shared rounds · last Mar 10, 2021
• VV-Bio Ventures2 shared rounds · last Mar 10, 2021
• AAdBio partners2 shared rounds · last Mar 10, 2021
• CCanaan Partners1 shared round · last Oct 11, 2023
• FFidelity1 shared round · last Oct 11, 2023
• AAsabys Partners1 shared round · last Oct 11, 2023
• EEQT Life Sciences1 shared round · last Oct 11, 2023
• WWalleye Capital1 shared round · last Oct 11, 2023
• PPfizer1 shared round · last Oct 11, 2023

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• GGoHub Ventures3 companies · 2 deals in 12 mo
• HHealthier Capital3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Pontifax, which is a subset of its real portfolio. API: /api/v1/investors/pontifax (get a free API key). More: the most active VC firms and new venture capital funds.